Media & Resources

IAVI Report

IAVI REPORT – VOL. 23, NO. 1, 2019

November 20, 2019

In 2007, I was in Cape Town to attend a symposium on the challenges of global vaccine development. At that meeting, and during my visits to nearby clinical research centers, the mood was somber. Just weeks before, two HIV vaccine efficacy trials, known as STEP and Phambili, had ground to a halt. These trials were testing…

Scientific Publications

Vaccination with Glycan Modified HIV NFL Envelope Trimer Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability

Press Releases

Biofabri, IAVI, and SATVI Collaborate on Clinical Trial of TB Vaccine Candidate MTBVAC in South African Adults

November 19, 2019

Trial to evaluate safety, dosing, and immunogenicity of novel TB vaccine candidate.

Press Releases

Award from U.S. Department of Defense to Advance Marburg Virus Vaccine Candidate Development

November 12, 2019

Marburg virus has epidemic potential and is a high-priority agent that poses a national security threat.

Features

HIV Vaccine Design Strategy Shows Promise in Proof-of-Principle Tests

November 1, 2019

Research published in Science could be applied beyond HIV to other diseases.

Features

IAVI Scientists and Partners Discuss Access Pathways for New HIV Prevention Options

November 1, 2019

In two recent publications, IAVI authors point to the need for an expanded global commitment to HIV vaccine development and suggest a suite of regulatory, policy, and implementation activities to ensure access to new HIV prevention tools.

Scientific Publications

Comparing Alcohol Use Disorders Identification Test AUDIT with Timeline Follow Back TLFB DSM 5 and Phosphatidylethanol PEth for the assessment of alcohol misuse among young people in Ugandan fishing communities

In The News

Clinical trial of vaccine shows 49.7% efficacy in preventing pulmonary TB infection

October 30, 2019

1…74 757677 78…218 of 218

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

IAVI REPORT – VOL. 23, NO. 1, 2019

Vaccination with Glycan Modified HIV NFL Envelope Trimer Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability

Biofabri, IAVI, and SATVI Collaborate on Clinical Trial of TB Vaccine Candidate MTBVAC in South African Adults

Award from U.S. Department of Defense to Advance Marburg Virus Vaccine Candidate Development

HIV Vaccine Design Strategy Shows Promise in Proof-of-Principle Tests

IAVI Scientists and Partners Discuss Access Pathways for New HIV Prevention Options

Comparing Alcohol Use Disorders Identification Test AUDIT with Timeline Follow Back TLFB DSM 5 and Phosphatidylethanol PEth for the assessment of alcohol misuse among young people in Ugandan fishing communities

Clinical trial of vaccine shows 49.7% efficacy in preventing pulmonary TB infection

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

IAVI REPORT – VOL. 23, NO. 1, 2019

Vaccination with Glycan Modified HIV NFL Envelope Trimer Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability

Biofabri, IAVI, and SATVI Collaborate on Clinical Trial of TB Vaccine Candidate MTBVAC in South African Adults

Award from U.S. Department of Defense to Advance Marburg Virus Vaccine Candidate Development

HIV Vaccine Design Strategy Shows Promise in Proof-of-Principle Tests

IAVI Scientists and Partners Discuss Access Pathways for New HIV Prevention Options

Comparing Alcohol Use Disorders Identification Test AUDIT with Timeline Follow Back TLFB DSM 5 and Phosphatidylethanol PEth for the assessment of alcohol misuse among young people in Ugandan fishing communities

Clinical trial of vaccine shows 49.7% efficacy in preventing pulmonary TB infection

Subscription Type